{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:00:37Z","timestamp":1782892837493,"version":"3.54.5"},"reference-count":129,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Invasive fungal disease (IFD) associated with Coronavirus Disease 2019 (COVID-19) has focussed predominantly on invasive pulmonary aspergillosis. However, increasingly emergent are non-Aspergillus fungal infections including candidiasis, mucormycosis, pneumocystosis, cryptococcosis, and endemic mycoses. These infections are associated with poor outcomes, and their management is challenged by delayed diagnosis due to similarities of presentation to aspergillosis or to non-specific features in already critically ill patients. There has been a variability in the incidence of different IFDs often related to heterogeneity in patient populations, diagnostic protocols, and definitions used to classify IFD. Here, we summarise and address knowledge gaps related to the epidemiology, risks, diagnosis, and management of COVID-19-associated fungal infections other than aspergillosis.<\/jats:p>","DOI":"10.3390\/jof8010058","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T01:14:02Z","timestamp":1641518042000},"page":"58","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Fungal Infections Other Than Invasive Aspergillosis in COVID-19 Patients"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0647-4314","authenticated-orcid":false,"given":"Kerri","family":"Basile","sequence":"first","affiliation":[{"name":"Centre for Infectious Diseases and Microbiology Laboratory Services, NSW Health Pathology\u2014Institute of Clinical Pathology and Medical Research, Westmead, NSW 2145, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0301-7110","authenticated-orcid":false,"given":"Catriona","family":"Halliday","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases and Microbiology Laboratory Services, NSW Health Pathology\u2014Institute of Clinical Pathology and Medical Research, Westmead, NSW 2145, Australia"},{"name":"Centre for Infectious Diseases and Microbiology\u2014Public Health, Westmead Hospital, Westmead, NSW 2145, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8796-283X","authenticated-orcid":false,"given":"Jen","family":"Kok","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases and Microbiology Laboratory Services, NSW Health Pathology\u2014Institute of Clinical Pathology and Medical Research, Westmead, NSW 2145, Australia"},{"name":"Centre for Infectious Diseases and Microbiology\u2014Public Health, Westmead Hospital, Westmead, NSW 2145, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon C-A.","family":"Chen","sequence":"additional","affiliation":[{"name":"Centre for Infectious Diseases and Microbiology Laboratory Services, NSW Health Pathology\u2014Institute of Clinical Pathology and Medical Research, Westmead, NSW 2145, Australia"},{"name":"Centre for Infectious Diseases and Microbiology\u2014Public Health, Westmead Hospital, Westmead, NSW 2145, Australia"},{"name":"Sydney Institute for Infectious Diseases, University of Sydney, Sydney, NSW 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"key":"ref_1","unstructured":"WHO (2021, September 08). Director-General\u2019s Opening Remarks at the Media Briefing on COVID-19\u201411 March 2020. Available online: https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020."},{"key":"ref_2","unstructured":"(2021, July 09). The World Health Organization\u2014WHO Lists Additional COVID-19 Vaccine for Emergency Use and Issues Interim Policy Recommendations. Available online: https:\/\/www.who.int\/news\/item\/07-05-2021-who-lists-additional-covid-19-vaccine-for-emergency-use-and-issues-interim-policy-recommendations."},{"key":"ref_3","unstructured":"(2021, September 01). The World Health Organization\u2014Tracking SARS-CoV-2 Variants. Available online: https:\/\/www.who.int\/en\/activities\/tracking-sars-cov-2-variants\/."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1152\/physiol.00019.2020","article-title":"Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression","volume":"35","author":"Bohn","year":"2020","journal-title":"Physiology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1001\/jama.2020.6266","article-title":"Rates of Co-Infection between SARS-CoV-2 and Other Respiratory Pathogens","volume":"323","author":"Kim","year":"2020","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/path.4124","article-title":"Danger-Associated Molecular Patterns (DAMPs) in Acute Lung Injury","volume":"229","author":"Tolle","year":"2013","journal-title":"J. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1164\/rccm.202004-1038LE","article-title":"COVID-19-Associated Pulmonary Aspergillosis","volume":"202","author":"Rijpstra","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e1645","DOI":"10.1093\/cid\/ciaa1342","article-title":"Invasive Fungal Disease Complicating Coronavirus Disease 2019: When It Rains, It Spores","volume":"73","author":"Hoenigl","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cmi.2020.07.041","article-title":"Incidence of Co-Infections and Superinfections in Hospitalized Patients with COVID-19: A Retrospective Cohort Study","volume":"27","author":"Sanjuan","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s11046-020-00462-9","article-title":"Fungal Co-Infections Associated with Global COVID-19 Pandemic: A Clinical and Diagnostic Perspective from China","volume":"185","author":"Song","year":"2020","journal-title":"Mycopathologia"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"100971","DOI":"10.1016\/j.mycmed.2020.100971","article-title":"Invasive Fungal Diseases during COVID-19: We Should Be Prepared","volume":"30","author":"Gangneux","year":"2020","journal-title":"J. De Mycol. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/myc.13096","article-title":"COVID-19 Associated Pulmonary Aspergillosis","volume":"63","author":"Koehler","year":"2020","journal-title":"Mycoses"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3201\/eid1606.100165","article-title":"Invasive Aspergillosis after Pandemic (H1N1) 2009","volume":"16","author":"Lat","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Magira, E.E., Chemaly, R.F., Jiang, Y., Tarrand, J., and Kontoyiannis, D.P. (2019). Outcomes in Invasive Pulmonary Aspergillosis Infections Complicated by Respiratory Viral Infections in Patients with Hematologic Malignancies: A Case-Control Study. Open Forum Infectious Diseases, Oxford University Press.","DOI":"10.1093\/ofid\/ofz247"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/cid\/ciaa007","article-title":"High Rates of Influenza-Associated Invasive Pulmonary Aspergillosis May Not Be Universal: A Retrospective Cohort Study from Alberta, Canada","volume":"71","author":"Schwartz","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/crj.12995","article-title":"Invasive Pulmonary Aspergillosis in Patients with Influenza Infection: A Retrospective Study and Review of the Literature","volume":"13","author":"Huang","year":"2019","journal-title":"Clin. Respir. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive Aspergillosis in Patients Admitted to the Intensive Care Unit with Severe Influenza: A Retrospective Cohort Study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_19","first-page":"100814","article-title":"COVID-19 and Pneumocystis Jirovecii Pneumonia: Back to the Basics","volume":"79","author":"Mouren","year":"2021","journal-title":"Respir. Med. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.2217\/fmb-2020-0156","article-title":"Systemic Mycoses: A Potential Alert for Complications in COVID-19 Patients","volume":"15","author":"Frases","year":"2020","journal-title":"Future Microbiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: A Systematic Review of Cases Reported Worldwide and in India","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s15010-021-01670-1","article-title":"COVID-19 and Mucormycosis Superinfection: The Perfect Storm","volume":"49","author":"Alhumaid","year":"2021","journal-title":"Infection"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and Managing COVID-19-Associated Pulmonary Aspergillosis: The 2020 ECMM\/ISHAM Consensus Criteria for Research and Clinical Guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_25","unstructured":"(2021, September 08). Advice on the Use of Masks in the Context of COVID-19. Interim Guidance. Geneva: World Health Organization. Available online: https:\/\/www.who.int\/Publications\/i\/Item\/Advice-on-the-Use-of-Masks-in-the-Community-during-Home-Care-and-in-Healthcare-Settings-in-the-Context-of-the-Novel-Coronavirus-(2019-Ncov)-Outbreak."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40249-020-00662-x","article-title":"Expression of the SARS-CoV-2 Cell Receptor Gene ACE2 in a Wide Variety of Human Tissues","volume":"9","author":"Li","year":"2020","journal-title":"Infect. Dis. Poverty"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41564-021-00908-w","article-title":"The Furin Cleavage Site in the SARS-CoV-2 Spike Protein Is Required for Transmission in Ferrets","volume":"6","author":"Peacock","year":"2021","journal-title":"Nat. Microbiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/modpathol.3800247","article-title":"Pulmonary Pathology of Severe Acute Respiratory Syndrome in Toronto","volume":"18","author":"Hwang","year":"2005","journal-title":"Mod. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7326\/M20-0533","article-title":"Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19","volume":"172","author":"Zhang","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s10067-020-05190-5","article-title":"Cytokine Storm in COVID-19: Pathogenesis and Overview of Anti-Inflammatory Agents Used in Treatment","volume":"39","author":"Soy","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1128\/JVI.01792-08","article-title":"Severe Acute Respiratory Syndrome (SARS) Coronavirus-Induced Lung Epithelial Cytokines Exacerbate SARS Pathogenesis by Modulating Intrinsic Functions of Monocyte-Derived Macrophages and Dendritic Cells","volume":"83","author":"Yoshikawa","year":"2009","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12026-014-8534-z","article-title":"T Cell-Mediated Immune Response to Respiratory Coronaviruses","volume":"59","author":"Channappanavar","year":"2014","journal-title":"Immunol. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1128\/JVI.74.7.3399-3403.2000","article-title":"Virus Clearance through Apoptosis-Dependent Phagocytosis of Influenza A Virus-Infected Cells by Macrophages","volume":"74","author":"Fujimoto","year":"2000","journal-title":"J. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Small, B.A., Dressel, S.A., Lawrence, C.W., Drake Iii, D.R., Stoler, M.H., Enelow, R.I., and Braciale, T.J. (2001). CD8 T Cell-Mediated Injury In Vivo Progresses in the Absence of Effector T Cells, Rockefeller University Press.","DOI":"10.1084\/jem.194.12.1835"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"37252","DOI":"10.1038\/srep37252","article-title":"Neutrophil Extracellular Traps Are Indirectly Triggered by Lipopolysaccharide and Contribute to Acute Lung Injury","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: Consider Cytokine Storm Syndromes and Immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"The RECOVERY Collaborative Group (2021). Dexamethasone in Hospitalized Patients with Covid-19. N. Engl. J. Med., 384, 693\u2013704.","DOI":"10.1056\/NEJMoa2021436"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"108393","DOI":"10.1016\/j.clim.2020.108393","article-title":"The Use of Anti-Inflammatory Drugs in the Treatment of People with Severe Coronavirus Disease 2019 (COVID-19): The Experience of Clinical Immunologists from China","volume":"214","author":"Zhang","year":"2020","journal-title":"Clin. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Baddley, J.W., Thompson, G.R., Chen, S.C.-A., White, P.L., Johnson, M.D., Nguyen, H., Schwartz, I.S., Spec, A., Ostrosky-Zeichner, L., and Jackson, B.R. (2021). COVID-19-Associated Invasive Fungal Infection. Open Forum Infect. Dis., ofab510.","DOI":"10.1093\/ofid\/ofab510"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/myc.13332","article-title":"Characteristics of Candidemia in COVID-19 Patients; Increased Incidence, Earlier Occurrence and Higher Mortality Rates Compared to Non-COVID-19 Patients","volume":"64","author":"Kayaaslan","year":"2021","journal-title":"Mycoses"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of Infectious Complications in Patients Taking Glucocorticosteroids","volume":"11","author":"Stuck","year":"1989","journal-title":"Clin. Infect. Dis."},{"key":"ref_43","unstructured":"OLUMIANT (Baricitinib) (2021, September 17). Tablets FDA Product Insert Reference ID: 4271150, Available online: https:\/\/www.Accessdata.Fda.gov\/Drugsatfda_docs\/Label\/2018\/207924s000lbl.Pdf."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1172\/JCI98814","article-title":"JAK1\/2 Inhibition with Baricitinib in the Treatment of Autoinflammatory Interferonopathies","volume":"128","author":"Sanchez","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"253","DOI":"10.7326\/0003-4819-159-4-201308200-00006","article-title":"Tofacitinib in Combination with Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients with Active Rheumatoid Arthritis","volume":"159","author":"Kremer","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1136\/annrheumdis-2016-210457","article-title":"Long-Term Safety of Tofacitinib for the Treatment of Rheumatoid Arthritis up to 8.5 Years: Integrated Analysis of Data from the Global Clinical Trials","volume":"76","author":"Cohen","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11926-016-0572-1","article-title":"Fungal Infections and New Biologic Therapies","volume":"18","author":"Vallabhaneni","year":"2016","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/rheumatology\/keq343","article-title":"Risk of Adverse Events Including Serious Infections in Rheumatoid Arthritis Patients Treated with Tocilizumab: A Systematic Literature Review and Meta-Analysis of Randomized Controlled Trials","volume":"50","author":"Campbell","year":"2011","journal-title":"Rheumatology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"R141","DOI":"10.1186\/ar3455","article-title":"Integrated Safety in Tocilizumab Clinical Trials","volume":"13","author":"Schiff","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"ref_50","unstructured":"KEVZARA\u00ae (Sarilumab) (2021, November 17). Full Prescribing Information (SAI-FPLR-SL-APR18a). Available online: https:\/\/Products.Sanofi.Us\/Kevzara\/Kevzara.pdf."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Permpalung, N., Chiang, T.P.-Y., Massie, A.B., Zhang, S.X., Avery, R.K., Nematollahi, S., Ostrander, D., Segev, D.L., and Marr, K.A. (2021). Coronavirus Disease 2019\u2013Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients. Clin. Infect. Dis., ciab223.","DOI":"10.1093\/cid\/ciab223"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e3606","DOI":"10.1093\/cid\/ciaa1065","article-title":"Epidemiology of Invasive Pulmonary Aspergillosis among COVID-19 Intubated Patients: A Prospective Study","volume":"73","author":"Bartoletti","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3201\/eid2704.204895","article-title":"COVID-19-Associated Pulmonary Aspergillosis, March-August 2020","volume":"27","author":"Sprute","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/S2213-2600(20)30237-X","article-title":"Prevalence of Putative Invasive Pulmonary Aspergillosis in Critically Ill Patients with COVID-19","volume":"8","author":"Alanio","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e1634","DOI":"10.1093\/cid\/ciaa1298","article-title":"A National Strategy to Diagnose Coronavirus Disease 2019-Associated Invasive Fungal Disease in the Intensive Care Unit","volume":"73","author":"White","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill Patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_57","first-page":"e12290","article-title":"Tocilizumab for COVID-19 Acute Respiratory Distress Syndrome: Outcomes Assessment Using the WHO Ordinal Scale","volume":"12","author":"Nasir","year":"2020","journal-title":"Cureus"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e02136-20","DOI":"10.1128\/JCM.02136-20","article-title":"COVID-19-Associated Invasive Aspergillosis: Data from the UK National Mycology Reference Laboratory","volume":"59","author":"Borman","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/myc.13225","article-title":"Increased Incidence of Candidemia in a Tertiary Care Hospital with the COVID-19 Pandemic","volume":"64","author":"Nucci","year":"2021","journal-title":"Mycoses"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Posteraro, B., Torelli, R., Vella, A., Leone, P.M., de Angelis, G., de Carolis, E., Ventura, G., Sanguinetti, M., and Fantoni, M. (2020). Pan-Echinocandin-Resistant Candida Glabrata Bloodstream Infection Complicating Covid-19: A Fatal Case Report. J. Fungi, 6.","DOI":"10.20944\/preprints202008.0198.v1"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Meijer, E.F.J., Dofferhoand, A.S.M., Meis, J.F., Hoiting, O., and Buil, J.B. (2020). Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report. J. Fungi, 6.","DOI":"10.3390\/jof6020079"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Arastehfar, A., Carvalho, A., Hong Nguyen, M., Hedayati, M.T., Netea, M.G., Perlin, D.S., and Hoenigl, M. (2020). Covid-19-Associated Candidiasis (Cac): An Underestimated Complication in the Absence of Immunological Predispositions?. J. Fungi, 6.","DOI":"10.3390\/jof6040211"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.fbr.2021.09.003","article-title":"The Rise in Cases of Mucormycosis, Candidiasis and Aspergillosis amidst COVID-19","volume":"38","author":"Ghosh","year":"2021","journal-title":"Fungal Biol. Rev."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Riche, C.V.W., Cassol, R., and Pasqualotto, A.C. (2020). Is the Frequency of Candidemia Increasing in Covid-19 Patients Receiving Corticosteroids?. J. Fungi, 6.","DOI":"10.3390\/jof6040286"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/myc.13258","article-title":"Epidemiology and Mycology of Candidaemia in Non-Oncological Medical Intensive Care Unit Patients in a Tertiary Center in the United States: Overall Analysis and Comparison between Non-COVID-19 and COVID-19 Cases","volume":"64","author":"Macauley","year":"2021","journal-title":"Mycoses"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Seagle, E.E., Jackson, B.R., Lockhart, S.R., Georgacopoulos, O., Nunnally, N.S., Roland, J., Barter, D.M., Johnston, H.L., Czaja, C.A., and Kayalioglu, H. (2021). The Landscape of Candidemia during the Coronavirus Disease 2019 (COVID-19) Pandemic. Clin. Infect. Dis., ciab562.","DOI":"10.1093\/cid\/ciab562"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jinf.2021.02.020","article-title":"A Retrospective Multicenter Analysis of candidaemia among COVID-19 Patients during the First UK Pandemic","volume":"82","author":"Denny","year":"2021","journal-title":"J. Infect."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Mulet Bayona, J.V., Tormo Palop, N., Salvador Garc\u00eda, C., Fuster Escriv\u00e1, B., Chanz\u00e1 Avi\u00f1\u00f3, M., Ortega Garc\u00eda, P., and Gimeno Cardona, C. (2021). Impact of the SARS-CoV-2 Pandemic in Candidaemia, Invasive Aspergillosis and Antifungal Consumption in a Tertiary Hospital. J. Fungi, 7.","DOI":"10.3390\/jof7060440"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"56","DOI":"10.15585\/mmwr.mm7002e3","article-title":"MMWR, Candida Auris Outbreak in a COVID-19 Specialty Care Unit\u2014Florida, July\u2013August 2020","volume":"70","author":"Prestel","year":"2019","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and Update of the Consensus Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-017-1763-5","article-title":"Combined Use of Serum (1,3)-\u03b2-d-Glucan and Procalcitonin for the Early Differential Diagnosis between Candidaemia and Bacteraemia in Intensive Care Units","volume":"21","author":"Giacobbe","year":"2017","journal-title":"Crit. Care"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1093\/jac\/dkw112","article-title":"(1,3)-\u03b2-d-Glucan-Based Antifungal Treatment in Critically Ill Adults at High Risk of Candidaemia: An Observational Study","volume":"71","author":"Posteraro","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/cid\/civ1194","article-title":"Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Jeican, I.I., Ini\u0219ca, P., Gheban, D., T\u0103b\u0103ran, F., Alua\u0219, M., Trombitas, V., Cristea, V., Crivii, C., Junie, L.M., and Albu, S. (2021). COVID-19 and Pneumocystis Jirovecii Pulmonary Coinfection\u2014the First Case Confirmed through Autopsy. Medicina, 57.","DOI":"10.3390\/medicina57040302"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"de Francesco, M.A., Alberici, F., Bossini, N., Scolari, F., Pascucci, F., Tomasoni, G., and Caruso, A. (2020). Pneumocystis Jirevocii and SARS-CoV-2 Co-Infection: A Common Feature in Transplant Recipients?. Vaccines, 8.","DOI":"10.3390\/vaccines8030544"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s15010-021-01630-9","article-title":"Narrative Review of the Relationship between COVID-19 and PJP: Does It Represent Coinfection or Colonization?","volume":"49","author":"Chong","year":"2021","journal-title":"Infection"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/cid\/ciaa906","article-title":"Pneumocystis Jirovecii Pneumonia and Severe Acute Respiratory Syndrome Coronavirus 2 Coinfection in a Patient With Newly Diagnosed HIV-1 Infection","volume":"72","author":"Mang","year":"2021","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1097\/QAD.0000000000002571","article-title":"Coronavirus Disease 2019 and Pneumocystis Jirovecii Pneumonia: A Diagnostic Dilemma in HIV","volume":"34","author":"Coleman","year":"2020","journal-title":"AIDS"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1164\/rccm.202003-0766LE","article-title":"A Case of COVID-19 and Pneumocystis Jirovecii Coinfection","volume":"202","author":"Menon","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1164\/rccm.202007-2938LE","article-title":"COVID-19\u2013Related Respiratory Failure and Lymphopenia Do Not Seem Associated with Pneumocystosis","volume":"202","author":"Blaize","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jinf.2020.10.034","article-title":"The Presence of Pneumocystis Jirovecii in Critically Ill with COVID-19","volume":"82","author":"Alanio","year":"2021","journal-title":"J. Infect."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Gerber, V., Ruch, Y., Chamaraux-Tran, T.N., Oulehri, W., Schneider, F., Lindner, V., Greigert, V., Denis, J., Brunet, J., and Danion, F. (2021). Detection of Pneumocystis Jirovecii in Patients with Severe Covid-19: Diagnostic and Therapeutic Challenges. J. Fungi, 7.","DOI":"10.3390\/jof7080585"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2141.2002.03419.x","article-title":"Pneumocystis Carinii Pneumonia in Patients with Malignant Haematological Diseases: 10 Years\u2019 Experience of Infection in GIMEMA Centres","volume":"117","author":"Pagano","year":"2002","journal-title":"Br. J. Haematol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.pt.2021.07.010","article-title":"Pneumocystis Pneumonia in the COVID-19 Pandemic Era: Similarities and Challenges","volume":"37","author":"Matos","year":"2021","journal-title":"Trends Parasitol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/jac\/dkw156","article-title":"ECIL Guidelines for the Diagnosis of Pneumocystis Jirovecii Pneumonia in Patients with Haematological Malignancies and Stem Cell Transplant Recipients","volume":"71","author":"Alanio","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1093\/jac\/dkw158","article-title":"ECIL Guidelines for Treatment of Pneumocystis Jirovecii Pneumonia in Non-HIV-Infected Haematology Patients","volume":"71","author":"Maschmeyer","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Gentile, I., Viceconte, G., Lanzardo, A., Zotta, I., Zappulo, E., Pinchera, B., Scotto, R., Schiano Moriello, N., Foggia, M., and Giaccone, A. (2021). Pneumocystis Jirovecii Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph182111399"},{"key":"ref_89","first-page":"e10726","article-title":"Rhino-Orbital Mucormycosis Associated With COVID-19","volume":"12","author":"Mehta","year":"2020","journal-title":"Cureus"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s15010-020-01561-x","article-title":"A Challenging Complication Following SARS-CoV-2 Infection: A Case of Pulmonary Mucormycosis","volume":"49","author":"Pasero","year":"2020","journal-title":"Infection"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"746","DOI":"10.5946\/ce.2020.180","article-title":"Rare and Fatal Gastrointestinal Mucormycosis (Zygomycosis) in a COVID-19 Patient: A Case Report","volume":"53","author":"Ribeiro","year":"2020","journal-title":"Clin. Endosc."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11046-021-00528-2","article-title":"Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature","volume":"186","author":"Garg","year":"2021","journal-title":"Mycopathologia"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4103\/ijo.IJO_3763_20","article-title":"COVID-19 and Orbital Mucormycosis","volume":"69","author":"Sarkar","year":"2021","journal-title":"Indian J. Ophthalmol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4103\/ijo.IJO_3774_20","article-title":"Mucor in a Viral Land: A Tale of Two Pathogens","volume":"69","author":"Sen","year":"2021","journal-title":"Indian J. Ophthalmol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e241663","DOI":"10.1136\/bcr-2021-241663","article-title":"COVID-19 Triggering Mucormycosis in a Susceptible Patient: A New Phenomenon in the Developing World?","volume":"14","author":"Revannavar","year":"2021","journal-title":"BMJ Case Rep."},{"key":"ref_96","first-page":"633","article-title":"Mixed Mold Infection with Aspergillus Fumigatus and Rhizopus Microsporus in a Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patient","volume":"51","author":"Bellanger","year":"2021","journal-title":"Infect. Dis. Now"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.cmi.2020.06.026","article-title":"Invasive Pulmonary Fusariosis in an Immunocompetent Critically Ill Patient with Severe COVID-19","volume":"26","author":"Poignon","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global Guideline for the Diagnosis and Management of Mucormycosis: An Initiative of the European Confederation of Medical Mycology in Cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"John, T.M., Jacob, C.N., and Kontoyiannis, D.P. (2021). When Uncontrolled Diabetes Mellitus and Severe Covid-19 Converge: The Perfect Storm for Mucormycosis. J. Fungi, 7.","DOI":"10.3390\/jof7040298"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/myc.13353","article-title":"Mucormycosis and COVID-19: An Epidemic within a Pandemic in India","volume":"64","author":"Selarka","year":"2021","journal-title":"Mycoses"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and Invasive Fungal Infections","volume":"362","author":"Lionakis","year":"2003","journal-title":"Lancet"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Narayanan, S., Chua, J.V., and Baddley, J.W. (2021). Coronavirus Disease 2019\u2013Associated Mucormycosis: Risk Factors and Mechanisms of Disease. Clin. Infect. Dis., ciab726.","DOI":"10.1093\/cid\/ciab726"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"490.e1","DOI":"10.1016\/j.cmi.2014.12.021","article-title":"Invasive Infections Due to Filamentous Fungi Other than Aspergillus: Epidemiology and Determinants of Mortality","volume":"21","author":"Slavin","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1093\/mmy\/myx113","article-title":"Scedosporium and Lomentospora: An Updated Overview of Underrated Opportunists","volume":"56","author":"Pellon","year":"2018","journal-title":"Med. Mycol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1016\/S1473-3099(20)30784-2","article-title":"Global Guideline for the Diagnosis and Management of Rare Mould Infections: An Initiative of the European Confederation of Medical Mycology in Cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology","volume":"21","author":"Hoenigl","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Chen, S.C.A., Halliday, C.L., Hoenigl, M., Cornely, O.A., and Meyer, W. (2021). Scedosporium and Lomentospora Infections: Contemporary Microbiological Tools for the Diagnosis of Invasive Disease. J. Fungi, 7.","DOI":"10.3390\/jof7010023"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1093\/mmy\/myx101","article-title":"Challenges in the Diagnosis and Treatment of Mucormycosis","volume":"56","author":"Skiada","year":"2018","journal-title":"Med. Mycol."},{"key":"ref_108","first-page":"2324709620972244","article-title":"An Acute Pulmonary Coccidioidomycosis Coinfection in a Patient Presenting With Multifocal Pneumonia With COVID-19","volume":"8","author":"Chang","year":"2020","journal-title":"J. Investig. Med. High Impact Case Rep."},{"key":"ref_109","first-page":"2324709620930540","article-title":"The Coincidence of 2 Epidemics, Coccidioidomycosis and SARS-CoV-2: A Case Report","volume":"8","author":"Shah","year":"2020","journal-title":"J. Investig. Med. High Impact Case Rep."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/milmed\/usab132","article-title":"Accelerated Progression of Disseminated Coccidioidomycosis Following SARS-CoV-2 Infection: A Case Report","volume":"186","author":"Krauth","year":"2021","journal-title":"Mil. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3201\/eid2705.204661","article-title":"Coccidioidomycosis and COVID-19 Co-Infection, United States, 2020","volume":"27","author":"Heaney","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1177\/0956462420957518","article-title":"COVID-19 Associated with AIDS-Related Disseminated Histoplasmosis: A Case Report","volume":"31","author":"Bertolini","year":"2020","journal-title":"Int. J. STD AIDS"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Messina, F.A., Marin, E., Caceres, D.H., Romero, M., Depardo, R., Priarone, M.M., Rey, L., V\u00e1zquez, M., Verweij, P.E., and Chiller, T.M. (2020). Coronavirus Disease 2019 (Covid-19) in a Patient with Disseminated Histoplasmosis and Hiv\u2014a Case Report from Argentina and Literature Review. J. Fungi, 6.","DOI":"10.3390\/jof6040275"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11046-020-00505-1","article-title":"COVID-19-Associated Histoplasmosis in an AIDS Patient","volume":"186","author":"Basso","year":"2021","journal-title":"Mycopathologia"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00259-020-04932-6","article-title":"Incidental Finding of COVID-19 Infection after [68Ga]Ga-PSMA-11 PET\/CT Imaging in a Patient with Prostate Cancer","volume":"48","author":"Stasiak","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1055\/s-0040-1702194","article-title":"Endemic Fungi Presenting as Community-Acquired Pneumonia: A Review","volume":"41","author":"Azar","year":"2020","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1513\/AnnalsATS.201308-286FR","article-title":"Update on the Diagnosis of Pulmonary Coccidioidomycosis","volume":"11","author":"Malo","year":"2014","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_118","first-page":"1612","article-title":"Laboratory Diagnostics for Histoplasmosis","volume":"56","author":"Azar","year":"2018","journal-title":"J. Clin. Microbiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1086\/588300","article-title":"Clinical Practice Guidelines for the Management of Blastomycosis: 2008 Update by the Infectious Diseases Society of America","volume":"46","author":"Chapman","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/521259","article-title":"Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America","volume":"45","author":"Wheat","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1093\/cid\/ciw360","article-title":"2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis","volume":"63","author":"Galgiani","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Cafardi, J., Haas, D., Lamarre, T., and Feinberg, J. (2021). Opportunistic Fungal Infection Associated with COVID-19. Open Forum Infectious Diseases, Oxford University Press.","DOI":"10.1093\/ofid\/ofab016"},{"key":"ref_123","first-page":"1","article-title":"Cryptococcus Neoformans Meningoencephalitis in an Immunocompetent Patient after COVID-19 Infection","volume":"2021","author":"Ghanem","year":"2021","journal-title":"Case Rep. Infect. Dis."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1007\/s42399-020-00574-9","article-title":"Detected SARS-CoV-2 in Ascitic Fluid Followed by Cryptococcemia: A Case Report","volume":"2","author":"Passarelli","year":"2020","journal-title":"SN Compr. Clin. Med."},{"key":"ref_125","first-page":"e8254","article-title":"Disseminated Cryptococcosis in a Patient With Metastatic Prostate Cancer Who Died in the Coronavirus Disease 2019 (COVID-19) Outbreak","volume":"12","author":"Passerini","year":"2020","journal-title":"Cureus"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mmcr.2021.10.001","article-title":"Disseminated Cryptococcus Neoformans Infection Associated to COVID-19","volume":"34","author":"Herrera","year":"2021","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/313992","article-title":"Epidemiology and Host-and Variety-Dependent Characteristics of Infection Due to Cryptococcus Neoformans in Australia and New Zealand","volume":"31","author":"Chen","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2002554","DOI":"10.1183\/13993003.02554-2020","article-title":"Confronting and Mitigating the Risk of COVID-19 Associated Pulmonary Aspergillosis","volume":"56","author":"Youngs","year":"2020","journal-title":"Eur. Respir. J."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/8\/1\/58\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:00:35Z","timestamp":1760364035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/8\/1\/58"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,6]]},"references-count":129,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["jof8010058"],"URL":"https:\/\/doi.org\/10.3390\/jof8010058","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,6]]}}}